Back to News
Market Impact: 0.15
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
Source: Nasdaq
Healthcare & Biotech
The First Trust NYSE Arca Biotechnology Index Fund outperformed the VanEck Biotech ETF over both the past year and the past five years. The article provides no return figures or explanation for the relative performance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Merck’s remigromig meets non-inferiority goal in DME trial
- Bank of America is bullish on these top stocks ahead of earnings
- Big Tech is betting $700 billion on AI. Healthcare will decide whether the bet pays off
- Trump’s Medicaid cuts strip health coverage from some legal immigrants—including refugees and victims of human trafficking
- Taiz hospitals near collapse as Houthis tighten siege: Yemen government
- How de-extincting dire wolves and woolly mammoths may extend human life